BioSpace News Archive

Flagship Pioneering, a unique life sciences innovation enterprise, today announced the appointment of Prakash Raman, Ph.D. to the post of Senior Partner and the newly created role of Chief Business Development Officer

Circuit edit (CE) engineers, whether supporting designers or in service labs, who are looking for a cost-effective solution can increase their productivity with the next-generation Thermo Scientific Centrios circuit edit system

Generates repeatable, high-quality semiconductor analysis to accelerate device development and maximize yields

Additions support Obsidian’s active program development, operational build-out and ongoing regulatory discussions

Pharmascience Inc. is proud to announce that the US Food and Drug Administration (FDA) communicated on October 31, 2019, that the abbreviated new drug application (ANDA) for Pharmascience’s generic version of Paliperidone Palmitate Extended-Release Injectable Suspension prefilled syringes, is accepted for review

AtriCure, Inc., a leading innovator in surgical treatments for atrial fibrillation and left atrial appendage management, announced that the company will be participating in the upcoming Piper Jaffray 31st Annual Healthcare Conference in New York City.

UroGen Pharma Ltd., a clinical-stage biopharmaceutical company developing treatments to address unmet needs in uro-oncology, announced financial results for the third quarter ended September 30, 2019 and provided an overview of the Company’s recent developments.

Net sales increase 10.6% to $7,690,000, operating income was $409,000 for second quarter

Funding expected to extend Company’s cash runway into 2021, well past its expected topline data readouts for global Phase 3 studies for vadadustat;

Avanir Pharmaceuticals, Inc. announced that it will continue the clinical development program of AVP-786 for the treatment of agitation in patients with Alzheimer’s dementia.